TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition

Overview of attention for article published in Immunogenetics, December 2011

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 48 Dimensions

Readers on

mendeley: 97 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

COMBINATION THERAPY WITH PD-1 SIGNAL INHIBITOR

Application WO-2022181515-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.